On the contrary, Acrp30 levels did not change after Ig replacement therapy in patients affected with a non-immunodeficiency syndrome, namely, CIDP, which indicates that Acrp30 plays a role in CVID. Here, ADIPOQ is linked to inborn error of immunity.